Ribavirin Tablet, Film Coated
Product Images NDC 65862-207

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 65862-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg (168 Tablet Bottle)

Package Label-principal Display Panel (200 mg (168 Tablet Bottle)
This text describes a medication called "Ribavirin Tahlets, USP." It includes instructions for pharmacists to dispense a medication guide to each patient. The medication contains 200 mg of Ribavirin USP per film-coated tablet, and the dosage information can be found in the package insert. It is recommended to store the medication at a temperature range of 20° to 30°C. Important information can be found in the medication guide, such as avoiding pregnancy while taking the medication. The medication is distributed by Aurobindo Pharma USA, Inc. and was made in India. The code "TS/DRUGS/19/1993" is also present.*
FDA Label Image

Chemical Structure (Ribavirin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.